IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Initial FDA and EMA Advice on Presendin Development, page-3

  1. 583 Posts.
    lightbulb Created with Sketch. 4970
    Very smart move by IXC team to get the boundaries negotiated and set early, increasing chances of approval if the study meets its endpoints.
    All good news as I see it, with a speedier pathway in EU.
    Thumbs up from me.

 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.